Literature DB >> 1970617

Alpha 1 B- but not alpha 1 A-adrenoceptors mediate inositol phosphate generation.

M C Michel1, G Hanft, G Gross.   

Abstract

We used novel highly subtype-selective antagonists to study whether alpha 1A- and/or alpha 1B-adrenoceptors mediate the stimulation of inositol phosphate generation by noradrenaline in rat cerebral cortex. Phentolamine (10 microM) and prazosin (100 nM) completely abolished the stimulated inositol phosphate generation. The alpha 1A-selective antagonists 5-methyl-urapidil (100 nM) and (+)- and (-)-niguldipine (10 nM) caused only weak inhibition or none at all although these concentrations occupied alpha 1A-adrenoceptors almost completely. In contrast, pretreatment with the irreversible alpha 1B-selective chloroethylclonidine reduced the noradrenaline-stimulated inositol phosphate generation by 76 +/- 8%. These data demonstrate that alpha 1B-adrenoceptors couple to inositol phosphate generation; the signal transduction system of alpha 1A-adrenoceptors remains unclear.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970617     DOI: 10.1007/bf00180666

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  14 in total

1.  Alpha 1-adrenoceptors: the ability of various agonists and antagonists to discriminate between two distinct [3H]prazosin binding sites.

Authors:  G Hanft; G Gross; J J Beckeringh; C Korstanje
Journal:  J Pharm Pharmacol       Date:  1989-10       Impact factor: 3.765

2.  Molecular characterization of the human beta 3-adrenergic receptor.

Authors:  L J Emorine; S Marullo; M M Briend-Sutren; G Patey; K Tate; C Delavier-Klutchko; A D Strosberg
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

3.  Alpha 1-adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle.

Authors:  C Han; P W Abel; K P Minneman
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

Review 4.  Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+.

Authors:  K P Minneman
Journal:  Pharmacol Rev       Date:  1988-06       Impact factor: 25.468

Review 5.  Subtypes of alpha 2-adrenoceptors: pharmacological and molecular biological evidence converge.

Authors:  D B Bylund
Journal:  Trends Pharmacol Sci       Date:  1988-10       Impact factor: 14.819

6.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

7.  Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype.

Authors:  J W Regan; T S Kobilka; T L Yang-Feng; M G Caron; R J Lefkowitz; B K Kobilka
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

8.  Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists.

Authors:  G Hanft; G Gross
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

9.  Comparison of alpha 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101.

Authors:  K P Minneman; C Han; P W Abel
Journal:  Mol Pharmacol       Date:  1988-05       Impact factor: 4.436

10.  Thyroid-dependent alterations of myocardial adrenoceptors and adrenoceptor-mediated responses in the rat.

Authors:  G Gross; I Lues
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-06       Impact factor: 3.000

View more
  9 in total

1.  Regulation of rat cortical 5-hydroxytryptamine2A receptor-mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramine.

Authors:  Gerard J Marek
Journal:  Eur Neuropsychopharmacol       Date:  2008-02-21       Impact factor: 4.600

2.  Alpha-adrenoceptor subtypes in dog saphenous vein that mediate contraction and inositol phosphate production.

Authors:  P E Hicks; M Barras; G Herman; P Mauduit; J M Armstrong; B Rossignol
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

3.  Comparison of alpha 1A- and alpha 1B-adrenoceptor coupling to inositol phosphate formation in rat kidney.

Authors:  R Büscher; W Erdbrügger; T Philipp; O E Brodde; M C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-12       Impact factor: 3.000

4.  Alpha 1-adrenoceptors and calcium sources in adrenergic neurogenic contractions of rat vas deferens.

Authors:  R Bültmann; A K Kurz; K Starke
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

5.  Alpha 1A and alpha 1B-adrenoceptors enhance inositol phosphate generation in rat renal cortex.

Authors:  M C Michel; R Büscher; T Philipp; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

6.  Sources of calcium and alpha 1-adrenoceptor-mediated contraction in rat tail artery.

Authors:  A Tabernero; N M Vivas; E Vila
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

7.  Alpha 1-adrenoceptor subtype affinities of drugs for the treatment of prostatic hypertrophy. Evidence for heterogeneity of chloroethylclonidine-resistant rat renal alpha 1-adrenoceptor.

Authors:  M C Michel; R Büscher; J Kerker; H Kraneis; W Erdbrügger; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

8.  Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat.

Authors:  D R Blue; D W Bonhaus; A P Ford; J R Pfister; N A Sharif; I A Shieh; R L Vimont; T J Williams; D E Clarke
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

9.  Calcium-dependence of histamine- and carbachol-induced inositol phosphate formation in human U373 MG astrocytoma cells: comparison with HeLa cells and brain slices.

Authors:  J A Arias-Montaño; V Berger; J M Young
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.